[Herpes Zoster Ophthalmicus after Pfizer BNT162b2 and Moderna mRNA-1273 vaccination in two young and immunocompetent patients].

Autor: Amblard MA; Centre ophtalmologique Place de l'Étoile, Luxembourg., Costantini E; Centre ophtalmologique Place de l'Étoile, Luxembourg; Centre laser Monterey, Luxembourg., Hayek G; Centre ophtalmologique Place de l'Étoile, Luxembourg., Ricaud X; Centre ophtalmologique Place de l'Étoile, Luxembourg; Centre laser Monterey, Luxembourg. Electronic address: docteur.ricaud@gmail.com.

Publikováno v: Journal francais d'ophtalmologie [J Fr Ophtalmol] 2022 Nov; Vol. 45 (9), pp. 1000-1003. Date of Electronic Publication: 2022 Sep 23.

Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study

Autor: Shasha, David, Bareket, Ronen, Sikron, Fabienne Hershkowitz, Gertel, Omer, Tsamir, Judith, Dvir, David, Mossinson, David, Heymann, Anthony D., Zacay, Galia

Publikováno v: In Clinical Microbiology and Infection January 2022 28(1):130-134

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany

Autor: Rolf Schwarzer, Sabine D. Freys, Nick Neuwinger, Nina Beikert, Bettina Eberspächer, Anke Edelmann, Marta Zuchowski, Inga Slothouwer, Angela Stein, Kathrin Theil, Peter Menzel, Jörg Hofmann

Publikováno v: Immunity, Inflammation and Disease, Vol 9, Iss 4, Pp 1809-1814 (2021)

Abstract Background: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2

Externí odkaz: https://doaj.org/article/9d4c59a316a74985af8e11064f6b7dd4

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.